Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies

Hanny Al-Samkari, MD, Aric D Parnes, MD, Katayoon Goodarzi, MD, James I Weitzman, MD, Jean M. Connors, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 389.

https://doi.org/10.1182/blood-2019-123864

Published: 2019

Journal Articles

Historical Analysis of a Cohort of Chilean Patients Treated with Autologous Stem Cell Transplantation Since 1993: Optimization of Stem Cell Collections, Risk Factors for Poor Mobilizers and Efficient Plerixafor Use

Mauricio Sarmiento Maldonado, MD, Jara Veronica, Silvana Arellano, Soto Katherine, Carla Lorca, Isabel Pizarro, Pablo Bertin, MD, Mauricio Galleguillos, Elizabeth Rivera, Isabel Rodriguez, Nicole Beffermann, Mauricio Ocqueteau, MD, Jaime Pereira, MD

Blood (2019) 134 (Supplement_1): 5641.

https://doi.org/10.1182/blood-2019-124328

Published: 2019

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

Fertility Preservation in Pediatric and Adolescent Patients Undergoing HSCT: a Cross-Sectional Survey of the EBMT Pediatric WP

Tamara Diesch, MD, Alicia Rovo, MD, Nicolas von der Weid, MD, Maura Faraci, MD, Marta Pillon, MD, Arnaud Dalissier, Jean-Hugues Dalle, MD PhD Prof., Peter Bader, MD

Blood (2016) 128 (22): 4611.

https://doi.org/10.1182/blood.V128.22.4611.4611

Published: 2016

Journal Articles

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Smita Bhatia, MD, MPH, Cor van den Bos, MD, PhD, Can-Lan Sun, PhD, Jillian Birch, MD, Lisa Diller, MD, Kimberley Dilley, MD, MPH, FAAP, Jill Ginsberg, Laura Therese Martin, MD, Rajaram Nagarajan, MD, MS, Joseph P. Neglia, MD, MPH, Monica Terenziani, MD, David Tishler, MD, Anna T Meadows, MD, Leslie L. Robison, PhD, MPH, Odile Oberlin, MD, Jennifer P. Berano Teh, MD

Blood (2013) 122 (21): 2992.

https://doi.org/10.1182/blood.V122.21.2992.2992

Published: 2013

Journal Articles

Chemotherapy with Granulocyte Colony Stimulating Factor (G-CSF) Alone Versus Granulocyte Colony Stimulating Factor (G-CSF) Plus Granulocyte-Macrophage Stimulating Factor (GM-CSF) for Hematopoietic Progenitor Cell Mobilization in Patients with Relapsed Non-Hodgkin’s Lymphomas (NHLs).

Chitra Hosing, MD, Mark Munsell, PhD, Uday Popat, MD, Martin Körbling, MD, Rosamar Valverde, Farzaneh Maadani, Partow Kebriaei, MD, Amin Alousi, MD, Marcos DeLima, MD, John McMannis, PhD, Elizabeth J. Shpall, MD, Muzaffar H. Qazilbash, MD, Paolo Anderlini, MD, Sergio Giralt, MD, Richard Champlin, MD, Issa Khouri, MD

Blood (2007) 110 (11): 1900.

https://doi.org/10.1182/blood.V110.11.1900.1900

Published: 2007

Journal Articles

Very High Birth Weight of Offspring Is Associated with an Increased Risk of Leukemia in Their Mothers; Results of a Population-Based Cohort Study.

Ora Paltiel, MDCM, MSc, Rebecca Yanetz, PhD, Ronit Calderon, MD, MPH, Orly Manor, PhD, Susan Harlap, MD, Yehiel Friedlander, PhD

Blood (2007) 110 (11): 4677.

https://doi.org/10.1182/blood.V110.11.4677.4677

Published: 2007

Journal Articles

A Randomized Trial Comparing the Effectiveness of Peripheral Blood Stem Cell Mobilization with Chemotherapy and Early vs Delayed Initiation of Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Lymphoma and Multiple Myeloma.

Isabelle A. Bence-Bruckler, MD, Sheryl McDiarmid, APN, Harold L. Atkins, MD, Mitchell Sabloff, MD, Isabelle Gauthier, PharmD, Lothar B. Huebsch, MD

Blood (2005) 106 (11): 2929.

https://doi.org/10.1182/blood.V106.11.2929.2929

Published: 2005

Journal Articles

High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices

Sandra J. Horning, Nelson J. Chao, Robert S. Negrin, Richard T. Hoppe, Gwynn D. Long, Wendy W. Hu, Ruby M. Wong, Byron W. Brown, Karl G. Blume

Blood (1997) 89 (3): 801–813.

https://doi.org/10.1182/blood.V89.3.801

Published: 1997

NARROW

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies

Historical Analysis of a Cohort of Chilean Patients Treated with Autologous Stem Cell Transplantation Since 1993: Optimization of Stem Cell Collections, Risk Factors for Poor Mobilizers and Efficient Plerixafor Use

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Fertility Preservation in Pediatric and Adolescent Patients Undergoing HSCT: a Cross-Sectional Survey of the EBMT Pediatric WP

Risk Of Solid Subsequent Malignant Neoplasms (SMNs) With Extended Follow-Up Of Childhood Hodgkin Lymphoma (HL) Survivors Is Comparable To The Risk In Known High-Risk Groups Within The General Population: Report From The Late Effects Study Group (LESG)

Chemotherapy with Granulocyte Colony Stimulating Factor (G-CSF) Alone Versus Granulocyte Colony Stimulating Factor (G-CSF) Plus Granulocyte-Macrophage Stimulating Factor (GM-CSF) for Hematopoietic Progenitor Cell Mobilization in Patients with Relapsed Non-Hodgkin’s Lymphomas (NHLs).

Very High Birth Weight of Offspring Is Associated with an Increased Risk of Leukemia in Their Mothers; Results of a Population-Based Cohort Study.

A Randomized Trial Comparing the Effectiveness of Peripheral Blood Stem Cell Mobilization with Chemotherapy and Early vs Delayed Initiation of Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Lymphoma and Multiple Myeloma.

High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only